Daniela K van Santen

6PUBLICATIONS
24CO-AUTHORS
Disease surveillanceBehavioural epidemiologyCourts and sentencingCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 18, 2025
Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV.

Daniela K van Santen, Mathieu Chalouni, Juan Berenguer

|Jan 30, 2023
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials.

Daniela K van Santen, Sara Lodi, Paul Dietze

|Jun 20, 2022
Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs.

Michael W Traeger, Daniela K van Santen, Rachel Sacks-Davis

|Mar 31, 2021
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial.

Daniela K van Santen, Anders Boyd, Amy Matser

|Jan 07, 2021
Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspective.

Daniela K van Santen, Roel A Coutinho, Anneke van den Hoek

|Jul 30, 2020
Hepatitis C elimination in people living with HIV - the importance of biomedical and behavioural interventions.

Daniela K van Santen, Rachel Sacks-Davis, Margaret Hellard

Pageof 1

Frequent Collaborators

2 joint publications

Margaret Hellard

2 joint publications

Lisa Maher

2 joint publications

Matthew Hickman

1 joint publications

Anders Boyd